Andrea R Zammit1, Charles B Hall2, David A Bennett3, Ali Ezzati2, Mindy J Katz2, Graciela Muniz-Terrera4, Richard B Lipton2. 1. Albert Einstein College of Medicine, Bronx, NY, USA. Electronic address: andrea.zammit@einstein.yu.edu. 2. Albert Einstein College of Medicine, Bronx, NY, USA. 3. Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, USA. 4. University of Edinburgh, Edinburgh, UK.
Abstract
INTRODUCTION: We classified individuals based on their baseline performance on cognitive measures and investigated the association between cognitive classifications and neuropathological findings ∼7 years later, as an external validator. METHODS: Brain autopsies of 779 decedents were examined. Baseline latent class analysis on 10 neuropsychological measures was previously assigned: mixed-domains impairment (n = 39, 5%), memory-specific impairment (n = 210, 27%), frontal impairment (n = 113, 14.5%), average cognition (n = 360, 46.2%), and superior cognition (n = 57, 7.3%). Linear regressions and risks ratios were used to examine the relation of latent class assignment at enrollment with neuropathological indices. RESULTS: Amyloid β, tau, and transactive response DNA-binding protein 43 were associated with mixed-domains impairment and memory-specific impairment classes ∼7 years before death. Moderate arteriolosclerosis was associated with membership in the frontal impairment class. DISCUSSION: Our findings support the use of latent class models that incorporate more comprehensive neuropsychological measures to classify cognitive impairment.
INTRODUCTION: We classified individuals based on their baseline performance on cognitive measures and investigated the association between cognitive classifications and neuropathological findings ∼7 years later, as an external validator. METHODS: Brain autopsies of 779 decedents were examined. Baseline latent class analysis on 10 neuropsychological measures was previously assigned: mixed-domains impairment (n = 39, 5%), memory-specific impairment (n = 210, 27%), frontal impairment (n = 113, 14.5%), average cognition (n = 360, 46.2%), and superior cognition (n = 57, 7.3%). Linear regressions and risks ratios were used to examine the relation of latent class assignment at enrollment with neuropathological indices. RESULTS: Amyloid β, tau, and transactive response DNA-binding protein 43 were associated with mixed-domains impairment and memory-specific impairment classes ∼7 years before death. Moderate arteriolosclerosis was associated with membership in the frontal impairment class. DISCUSSION: Our findings support the use of latent class models that incorporate more comprehensive neuropsychological measures to classify cognitive impairment.
Authors: Lisa M Broidy; Daniel S Nagin; Richard E Tremblay; John E Bates; Bobby Brame; Kenneth A Dodge; David Fergusson; John L Horwood; Rolf Loeber; Robert Laird; Donald R Lynam; Terrie E Moffitt; Gregory S Pettit; Frank Vitaro Journal: Dev Psychol Date: 2003-03
Authors: J A Schneider; R S Wilson; E J Cochran; J L Bienias; S E Arnold; D A Evans; D A Bennett Journal: Neurology Date: 2003-04-08 Impact factor: 9.910
Authors: Margery H Silver; Kathy Newell; Christopher Brady; E Tessa Hedley-White; Thomas T Perls Journal: Psychosom Med Date: 2002 May-Jun Impact factor: 4.312
Authors: D A Bennett; R S Wilson; J A Schneider; D A Evans; N T Aggarwal; S E Arnold; E J Cochran; E Berry-Kravis; J L Bienias Journal: Neurology Date: 2003-01-28 Impact factor: 9.910
Authors: Kathryn N Devlin; Laura Brennan; Laura Saad; Tania Giovannetti; Roy H Hamilton; David A Wolk; Sharon X Xie; Dawn Mechanic-Hamilton Journal: J Alzheimers Dis Date: 2022 Impact factor: 4.472
Authors: Andrew J Petkus; Diana Younan; Xinhui Wang; Daniel P Beavers; Mark A Espeland; Margaret Gatz; Tara Gruenewald; Joel D Kaufman; Helena C Chui; Joshua Millstein; Stephen R Rapp; JoAnn E Manson; Susan M Resnick; Gregory A Wellenius; Eric A Whitsel; Keith Widaman; Jiu-Chiuan Chen Journal: J Alzheimers Dis Date: 2021 Impact factor: 4.160
Authors: Andrea R Zammit; David A Bennett; Charles B Hall; Richard B Lipton; Mindy J Katz; Graciela Muniz-Terrera Journal: J Alzheimers Dis Date: 2020 Impact factor: 4.472
Authors: Ali Ezzati; Danielle J Harvey; Christian Habeck; Ashkan Golzar; Irfan A Qureshi; Andrea R Zammit; Jinshil Hyun; Monica Truelove-Hill; Charles B Hall; Christos Davatzikos; Richard B Lipton Journal: J Alzheimers Dis Date: 2020 Impact factor: 4.472
Authors: Shahram Oveisgharan; Lei Yu; Ana Capuano; Zoe Arvanitakis; Lisa L Barnes; Julie A Schneider; David A Bennett; Aron S Buchman Journal: Stroke Date: 2021-04-12 Impact factor: 10.170